Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank57
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-56.30M
↑ 13% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-64.79M
Historical baseline
PeriodValueYoY Change
TTM$-56.30M+45.3%
2024$-102.89M+3.9%
2023$-107.06M-27.9%
2022$-83.73M-0.2%
2021$-83.53M-80.9%
2020$-46.18M-79.9%
2019$-25.66M-98.1%
2018$-12.95M-